Non-specific prevention of infections in children
https://doi.org/10.21518/2079-701X-2016-1-114-117
Abstract
ARVI (acute respiratory viral infections, also often called ARD - acute respiratory disease) is a group of diseases that are similar in character and mostly characterized by a pathology of the respiratory system. If the pathogen is not identified, the patient is usually diagnosed with ARD, since the agent is not necessarily a virus. In developed countries, 18% of children aged 1--4 years suffer from acute respiratory viral infections [1]. Children aged 3 to 14 years suffer from ARVI most often. At the same time, children in the first year of life are practically not affected by acute respiratory viral infections. This is contributed by passive immunity which is acquired at birth and maintained during the first months of life thanks to breastfeeding. Influenza and ARVI account for 90% of all infectious pathologies and are the second leading cause of death from infectious diseases [2]. Delayed influenza mortality during epidemics can reach 100 cases per 100 thousand people [3]. Influenza epidemics cause enormous economic damage: in Russia, it equals more than 20 billion rubles each year [4].
Keywords
инфекция,
ОРИ,
профилактика,
иммунная система Рибомунил,
infection,
ARVI,
prevention,
immune system,
Ribomunyl
About the Authors
N. L. Kunelskaya
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
A. Y. Ivoylov
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
M. I. Kulagina
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
V. R. Pakina
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
V. V. Yanovskiy
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
A. I. Machulin
Research and Clinical Otorhinolaryngology Institute named after L.I. Sverzhevskiy
Russian Federation
Russian Federation
References
1. Шаханина И. Л. Социально-экономические аспекты медицинской патологии. М., 1974.
2. Подушкина А.В. Эпидемиологические особенности гриппа и ОРВИ в современных условиях и оценка эффективности специфической профилактики и изоляционно-ограничительных мероприятий. Автореферат на соискание уч. степени канд. мед наук. Пермь. 2012. 27 с.
3. Поздеев О.К., Покровский В.И. Медицинская микробиология, 2001. 765 с.
4. Онищенко Г.Г. Национальная концепция профилактики инфекций, связанных с оказанием медицинской помощи. 2011.
5. Bellanti J.A. Recurrent respiratory tract infections in pediatric patients. Drugs, 1997. 54, Suppl. 1: 1-4.
6. Brook I, Shak K. Bacteriology of adenoids and tonsils in children with recurrent adenotonsillitis. Ann. Otol. Rhinol. Laryngol, 2001. 110: 844-848.
7. Gehanno P, Barry B, Bingen B et al. Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr. Infect. Dis. J., 2001. 20: 570-573.
8. Коровина Н.А., Заплатников А.Л., Чебуркин А.В., Захарова И.Н. Часто и длительно болеющие дети: современные возможности иммунореабилитации. М.: Контимед, 2001. 68.
9. Замахина Е.В., Фомина В.Л., Кладова О.В. и др. Клинико-патогенетическое значение персистенции респираторных вирусов у часто болеющих детей. Педиатрия, 2009. 87, 3: 42-46.
10. Мокія-Сербіна С. О. Клініко-імунологчіна ефективність бактеріальних імунокоректорів при персистенції бактеріальних збудників у дітей, хворих на бронхіальну астму. Мокія С.О., Литвинова Т.В. // Вестн. физиотерапии и курортол. - 2006. - № 2. -С. 61-67.
11. Bacterial lysates and ribosomes as inducers of specific immune responses: a comparative study / Bene M. C. Kahl 4, Perruchet A. V [et.al.] // Scand. J. Immunol. -1993. - Vol. 38. - P. 496-498.
12. Brook I., Grober A.E. Dynamics of nasopharyngitis in children // Otolaryngol Head Neck Surg. - 2000. - Vol. 122. - P. 696-700.
13. Graham M.H. The epidemiology of acute respiratory infections in children and adults: a global perspective // Epidemiol. Rev. - 1990. - Vol. 120. - P. 149-178.
14. Джованни А. Росси. Методы диагностики и терапевтические возможности лечения рекуррентных респираторных инфекций у детей. РМЖ, 2014. 26: 1945-1950.
15. Опыт применения рибомунила в российской педиатрической практике: Пособие для педиатров. Союз педиатров России. М., 2002. С. 167.
16. Dussourd D, Hinterland Z, Pinel AM. Immunological studi. Arznei-mittelforschung,1980. 30: 132-141.Mallia P, Johnston SI. Respiratori Viruses: do the protect from or induce asthma. Allergy,2002. 57: 1118-112
17. Mora R. Int. J. Pediatr Otorlaryngol, 2002. 63: 111-118.
18. Shakhanina I. L. Socio-economic aspects of medical pathology. М., 1974.
19. Podushkina A.V. Epidemiological features of influenza and ARVI in current conditions and evaluation of the effectiveness of specific prevention and isolation-restrictive measures. Synopses of the PhD Med. dissertation. Perm. 2012. 27 p.
20. Pozdeev O.K., Pokrovsky V.I. Meditsinskaya Mikrobiologiya, 2001. 765 p.
21. Onischenko G.G. National concept of prevention of healthcare-associated infections. 2011.
22. Korovina N.A., Zaplatnikov A.L., Cheburkin A.V., Zakharova I.N. Frequently and chronically ill children: the potential of immune rehabilitation. М.: Kontimed, 2001. 68.
23. Zamakhina E.V., Fomina V.L., Kladova O.V. et al. Clinico-pathogenetic value of persistence of respiratory viruses in sickly children. Pediatriya, 2009. 87, 3: 42-46.
24. Giovanni A. Rossi. Methods of diagnosis and treatment options for recurrent respiratory infections in children. RMZ, 2014. 26: 1945-1950.
25. Experience with Ribomunyl in the Russian pediatric practice: Doctor's Manual. Union of Pediatricians of Russia. М., 2002. P. 167.
Review
For citations:
Kunelskaya NL, Ivoylov AY, Kulagina MI, Pakina VR, Yanovskiy VV, Machulin AI. Non-specific prevention of infections in children. Meditsinskiy sovet = Medical Council. 2016;1(1):114-117. (In Russ.) https://doi.org/10.21518/2079-701X-2016-1-114-117
Views:
862
Email this article 